Enhancing effects of salicylate on tonic and phasic block of Na+ channels by class 1 antiarrhythmic agents in the ventricular myocytes and the guinea pig papillary muscle-Reference-Cited by-同舟云学术

Enhancing effects of salicylate on tonic and phasic block of Na+ channels by class 1 antiarrhythmic agents in the ventricular myocytes and the guinea pig papillary muscle

Published:1999-05 Issue:2 Volume:1418 Page:320-334
ISSN:0005-2736
Container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes

Author:

Tanaka Yasunori,Hisatome Ichiro,Miyamoto Jiro,Urashima Tadashi,Ikeda Kaoru,Yamanouchi Yumi,Sasaki Norihito,Kinugawa Toru,Ogino Kazuhide,Igawa Osamu,Yoshida Akio,Shigemasa Chiaki,Kurata Yasutaka,Sato Ryoichi

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry,Biophysics

Reference31 articles.

1. ISIS-2 Collaborative Group, Lancet ii (1988) 349–360.

2. UK-TIA Study Group, Br. Med. J. 296 (1988) 320–331.

3. CAST Investigators, New Engl. J. Med. 321 (1989) 406–412.

4. Cardiac Arrhythmia Suppression Trial II (CAST II) Investigators, New Engl. J. Med. 327 (1992) 227–233.

5. Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spearmint (l-Carvone) Oil and Wintergreen (Methyl Salicylate) Oil Emulsion Is an Effective Immersion Anesthetic of Fishes;Journal of Fish and Wildlife Management;2011-12-01

2. Enhancing effects of salicylate on quinidine-induced block of human wild type and LQT3 related mutant cardiac Na+ channels;Biomedical Research;2011

3. Inhibition of Inward Rectifier K+ Currents by Angiotensin II in Rat Atrial Myocytes: Lack of Effects in Cells from Spontaneously Hypertensive Rats;Hypertension Research;2006

4. Effects of Angiotensin II on the Action Potential Durations of Atrial Myocytes in Hypertensive Rats;Hypertension Research;2005

5. Analysis of moricizine block of sodium current in isolated guinea-pig atrial myocytes;Vascular Pharmacology;2002-03